Member Info for Tillywhiz

Afternoon All
Had a few days in the fresh air re charging with nature ,

Sounds like a good old fashioned boxing match on here , with a few posters laced up which ironically is exactly what Hemo is doing against deadly diseases ,

& CAR T is certainly the way forward for the fight against cancer & Hemo are in the ring with Boxing gloves loaded with horseshoes .

Current position -

.Cash in the bank prior to raise & with the raise allows funding to Clinical trials as stated in the RNS
Vlad stated
‘ I am pleased to announce this placing, which will enable the Company to progress with these two key product candidates’.

.Superb science - on multiple mind boggling potential fronts - CBR , CAR-T
In Brief

CBR allows the development of:

(1) off-the-shelf cell therapies against infectious disease.

(2) biopharmaceuticals to eliminate any potential virus in the course of infection or to be used as a preventive treatment.

CAR-T
‘ The IND is needed to obtain authorization from the FDA to commence Phase I clinical trials of HEMO-CAR-T. Following completion of all tests across all PQ runs, data will be compiled for inclusion in the IND submission pack. ‘

23rd Mar 2023 1:32 pm RNS HEMO-CAR-T Analytical Release Tests Completed

From recent RNS -
The completion of the full set of analytical tests of all PQ runs is the last manufacturing requirement that is necessary for the submission of an Investigational New Drug ("IND") application to the US Food and Drug Administration ("FDA"), which is now in the course of preparation.

All tests completed & passed by Hemo & third party - just time & patience required in my grog filled lamps .

& Clinical trials next on the horizon - which is the big stock mover as noted by Vlad previously & I agree

Transformational year for Hemo imo , been here years & great to see the science tree at last potentially bearing mind boggling fruit for investors.

At current stock levels well under the placement price & expected IND clarification / Clinical trial update or any of Hemos other superb science updates , the stock looks cheap IMO & content to add at current levels .
Plenty of patience required .

Good luck to all invested

Fetch the IND Grog

Leno & all

Sorry for your recent loss ,

Nice honest post dude ,
However You will never stop the toxic rot on these chat forums as greed fuelled by money is involved
& these forums give a platform for un vetted individuals to vent there personal frustrations on others , showing a lack in personal responsibility for one’s actions .

Keep it light hearted & keep it non personal should be the way , however that ain’t easy with some of the toxic rectoidal warriors loitering on these forums .

Health before wealth .

Evening all , well majority …

Been enjoying the beautiful British spring weather .. not ..

So an RNS landed updating the current position as best it can with current & obvious war situation outside the port window ,

Plenty of detail on the Mining side & Cash position better than many were claiming on here , although the legal cases may hang like a pair of lead testicles until resolved .

Altogether a detailed update & Asset sale on going in the shadows of which at current stock price is all i am interested in as I’m sure are many investors,

& hoping the Asset sale phoenix is pulled from the war ashes & stock re rate .

Even with this update RNS unlikely to quell swampy & his sweaty multi monikered mates shouting & whinging from the trees , on here on a daily basis .

although they could have left the party anytime if they held stock & if not , well that’s even more weird than banging Latex Lynda with perfumed beaver .

Perhaps further updates in coming months would be appreciated by stockholders.

Rums all Round

Gheko, Blas & all invested

Morning & hope all had & having a decent Easter with plenty of Grog ..
Agree & CAR T is certainly the way forward for the fight against cancer & Hemo are in the ring with Boxing gloves loaded with horseshoes .

Current position -

.Cash in the bank prior to raise & with the raise allows funding to Clinical trials as stated in the RNS
Vlad stated
‘ I am pleased to announce this placing, which will enable the Company to progress with these two key product candidates’.

.Superb science - on multiple mind boggling potential fronts - CBR , CAR-T
In Brief

CBR allows the development of:

(1) off-the-shelf cell therapies against infectious disease.

(2) biopharmaceuticals to eliminate any potential virus in the course of infection or to be used as a preventive treatment.

CAR-T
‘ The IND is needed to obtain authorization from the FDA to commence Phase I clinical trials of HEMO-CAR-T. Following completion of all tests across all PQ runs, data will be compiled for inclusion in the IND submission pack. ‘

23rd Mar 2023 1:32 pm RNS HEMO-CAR-T Analytical Release Tests Completed

From recent RNS -
The completion of the full set of analytical tests of all PQ runs is the last manufacturing requirement that is necessary for the submission of an Investigational New Drug ("IND") application to the US Food and Drug Administration ("FDA"), which is now in the course of preparation.

All tests completed & passed by Hemo & third party - just time & patience required in my grog filled lamps .

& Clinical trials next on the horizon - which is the big stock mover as noted by Vlad previously & I agree

Transformational year for Hemo imo , been here years & great to see the science tree at last potentially bearing mind boggling fruit for investors.

At current stock levels well under the placement price & expected IND clarification / Clinical trial update or any of Hemos other superb science updates , the stock looks cheap IMO & content to add at current levels .

Good luck to all invested

Fetch the IND Grog

Looks like some astute investor loading up the isa

Time Trade Prc Volume Buy/Sell Bid Ask Value
06-Apr-23 11:00:52 2.135 931,548 Unknown* 2.05 2.15 19.89k

Fetch the Ind grog

Evening all

Had a few days milking the fresh air ,

Personally have no problem with the tweets & pics , RNS will speak for themselves soon enough imo .
, anyhow let’s face it the tweet pictures could have been alot worse , especially if Vlad was pictured having some nose bag with Nicola Krankie Sturgeon & her dodgy uncle Festor husband

, bring on the Grant confirmation & IND / clinical trial RNS - transformational year for Hemo imo

Fetch the IND Grog

Evening All ,

These boards are unfortunately awash with agenda driven posters for whatever reason ,
Who knows who cares ,

unfortunately the RNS are the facts & speak for themselves in current position & potential future , so no amount of negativity will pack a punch .

Current position -

.Cash in the bank prior to raise & with the raise allows funding to Clinical trials as stated in the RNS
Vlad stated
‘ I am pleased to announce this placing, which will enable the Company to progress with these two key product candidates’.

.Superb science - on multiple mind boggling potential fronts - CBR , CAR-T
In Brief

CBR allows the development of:

(1) off-the-shelf cell therapies against infectious disease.

(2) biopharmaceuticals to eliminate any potential virus in the course of infection or to be used as a preventive treatment.

CAR-T
‘ The IND is needed to obtain authorization from the FDA to commence Phase I clinical trials of HEMO-CAR-T. Following completion of all tests across all PQ runs, data will be compiled for inclusion in the IND submission pack. ‘

23rd Mar 2023 1:32 pm RNS HEMO-CAR-T Analytical Release Tests Completed

From recent RNS -
The completion of the full set of analytical tests of all PQ runs is the last manufacturing requirement that is necessary for the submission of an Investigational New Drug ("IND") application to the US Food and Drug Administration ("FDA"), which is now in the course of preparation.

All tests completed & passed by Hemo & third party - just time & patience required in my grog filled lamps .

& Clinical trials next on the horizon - which is the big stock mover as noted by Vlad previously & I agree

Transformational year for Hemo imo , been here years & great to see the science tree at last potentially bearing fruit for investors.

Good luck to all invested

Fetch the IND Grog

We like a Friday blue finish , +5% & edging north

RNS could land at anytime , next weeks looking favourable imo
All positive in recent RNS & clearly states the Hemo roadmap

Fetch the IND Grog

Hedgy & all

Don’t worry about it dude , I’m confused all the time , mind you put that down to the excessive grog swigging .
Just an observation on the trade based on the time stamp & print ,
Anyhow sellers to feed the buyers & vice versa etc makes a healthy market & all that codswallop

Simple terms we need volume or an RNS or both & obviously gallons of IND Grog .

Sell -
Date Time Trade Prc Volume Buy/Sell Bid Ask Value
31-Mar-23 11:00:18 1.95 500,000 Unknown* 1.90 2.00 9,750 O

Vwap 1.935
Vol 3 million

As I stated & always state - this requires volume to shift north
Average vol 15 million

Fetch the Fomo friday IND Grog served by Nigella Lawson , wearing nothing but a lick of sizzling goose fat

There you go trades flipped = Blue waters
2p paid
We require Vol increase .

Fetch the FOMO Friday Grog

A few numbers + Shorts

Vol 1.7 million
Average 3 month vol - 15.5 million
Vwap 1.92
MCap 22 million
Stock sitting well below placement price .

Impatience in news brings traders opportunity in both directions in thin volume- imo

Looks like a short closing - 3 trades of the same stamp + time with one neg perhaps connected to some of negative posters on here of late ,
Desperate to get the price down & flip the trades .

31-Mar-23 09:33:51 1.94 320,000 Buy* 1.90 1.95 6,208 O
31-Mar-23 09:33:51 1.94 -320,000 Unknown* 1.90 1.95 -6,208 O
31-Mar-23 09:33:51 1.94 320,000 Buy* 1.90 1.95 6,208 O

Who knows who cares , IND / clinical trials simmering for all invested as highlighted via RNS
If news lands without stock , risk of being locked out .imo

Fetch the IND Friday Grog

Morning all ,
Back loitering after having treatment on my leg .

The forward map is highlighted in recent RNS , & all in preparation for clinical trials ,
Speckled Jim the carrier pigeon currently taking the IND submission pack to the relevant parties . All positive imo .

Exactly 2 month after the last relevant to CAR T

Previous RNS -
23rd Jan 2023 7:00 am RNS HEMO-CAR-T 3rd Process Qualification Run Completed

From that RNS -
This PQ run is the third of minimum three identical manufacturing runs required for the submission of an Investigational New Drug ("IND") application to the US Food and Drug Administration ("FDA"). The IND is needed to obtain authorization from the FDA to commence Phase I clinical trials of HEMO-CAR-T. Following completion of all tests across all PQ runs, data will be compiled for inclusion in the IND submission pack.

Thursdays - RNS
23rd Mar 2023 1:32 pm RNS HEMO-CAR-T Analytical Release Tests Completed

From recent RNS -
The completion of the full set of analytical tests of all PQ runs is the last manufacturing requirement that is necessary for the submission of an Investigational New Drug ("IND") application to the US Food and Drug Administration ("FDA"), which is now in the course of preparation. The IND is needed to obtain authorization from the FDA to commence Phase I clinical trials of HEMO-CAR-T. All PQ runs as well as analytical tests data will be compiled for inclusion in the IND submission pack.

CAR T progressing with IND submission pack ready to strap to Speckled Jim the carrier Pigeon en route to the Clinical Trials ,

Which by Vlads Submission , is the real meat of a Stock Shifter & I agree , just patience required ,
Traders & those expecting a fast buck will always get bored & sell up whilst awaiting news .
Each to there own .

& while CAR-T is brought to the boil via IND submission & clinical trials , Hemo also has CBR simmering …

CBR allows the development of:

(1) off-the-shelf cell therapies against infectious disease.

(2) biopharmaceuticals to eliminate any potential virus in the course of infection or to be used as a preventive treatment.

2023 could be a transformational year for Hemo & so far nothing but positive news via RNS & carrying out multiple strands of mind boggling superb science

Good luck to all invested ,

Fetch the IND Grog

TF & all

Not disagreeing , …

no whiff of news = no stock movement
Micro whiff of news / update = Trading spike
Putin slips on bar of soap & cracks his melon = sizeable stock shift & potential asset sale .

Rums & eyes peeled all Round

Evening All , well majority …

Been off deck a few days badly with a bad dose of COVID ,

However ,seemed to have caught the symptoms of this toxic board …

C - cranial
O- overload
V- via
I- irritating
D- Dipsticks

# Trading Agenda desperate for price fix .

We are where we are now after 14 months of war & minimal asset sale communication ,

Imo it’s like a tug a war between the following >

Green Energy Boom + Precious metals demand / asset sale Vs War situation + Fragile Markets

Which ironically is not dissimilar to the daily skirmishes / tug a war on this board …

positive investors accepting current market situations & one’s investment risks
Vs
Negaitive Swampy & his sweaty mates shouting blame & abuse at all investors , BOD , & the stock situation ,

We all have choices -- let’s all invested hope EUA toss an update on deck in coming weeks / months ,

However - any whiff of positive news & at current levels could certainly be huge upside .imo
So worth the hold in current position & certainly only blame one person for stock leathering as with many other stocks & that’s crazy Putin .

Rums & due a trading spike all Round

Morning to most , on this Sunday

Another week on crazy Volatile markets with daily developments.
Bank crisis , rampant inflation , interest rates rising & war situation creating a fragile financial coldren

The recent banking crisis with the collapse of SVB , with potential contagion of which I highlighted on here & was shot down by many & yet it rumbles on & on

contagion situation is spreading Credit Suisses now bailed out by UBS & would have bust .
& shows the vulnerability of the current markets & stocks around the world .

Now Deutsche Bank under the cosh , some serious toxic shenanigans found hidden in many heavy artillery banks books .

https://www.bloomberg.com/news/articles/2023-03-23/how-to-keep-accounts-safe-amid-bank-collapses?srnd=premium-

There maybe bargains out there however the volatility will continue & more stocks will be leathered imo . Banks ,( already started harshly ) financial,construction, property next ?

However With a few Phoenixes rising from the ashes let’s hope for all investors EUA is one of them especially from current stock levels .

Look at AMC was down 70% in 18 months now back to blue after confirmation of asset sale squeezed through the current sanction net , let’s hope EUA can do similar .

This quote taken from AMC RNS
"The delay in the completion of the Disposal was due to potential sanctions with regards to the 'Special Military Operation' and the potential risk associated to a third party involved in the fund transfer. This is something that the Company has successfully resolved, ensuring the Disposal was compliant with the current geopolitical situation."

The World business cogs keep turning & the Green energy boom require precious Metals which EUA has in its basket ,

Imo it’s like a tug a war between the following >

Green Energy Boom + Precious metals demand / asset sale Vs War situation + Fragile Markets

Which ironically is not dissimilar to the daily skirmishes / tug a war on this board …

positive investors accepting current market situations & one’s investment
Vs
Negaitive Swampy & his sweaty mates shouting blame & abuse at investors, BOD , & the stock situation ,

We all have choices - your investment your responsibility- let’s all invested hope EUA toss an update on deck in coming weeks / months ,
However - any whiff of positive news & at current levels could certainly be huge upside .imo
So worth the hold in current position .

Sunday Rums & Full English with all the trimmings , # A proper Yorkshire vein clogger

Morning all ,
Another positive week >

All together another very positive RNS , & all in preparation for clinical trials ,
Speckled Jim the carrier pigeon currently taking the IND submission pack to the relevant parties .

Exactly 2 month after the last relevant to CAR T

Previous RNS -
23rd Jan 2023 7:00 am RNS HEMO-CAR-T 3rd Process Qualification Run Completed

From that RNS -
This PQ run is the third of minimum three identical manufacturing runs required for the submission of an Investigational New Drug ("IND") application to the US Food and Drug Administration ("FDA"). The IND is needed to obtain authorization from the FDA to commence Phase I clinical trials of HEMO-CAR-T. Following completion of all tests across all PQ runs, data will be compiled for inclusion in the IND submission pack.

Thursdays - RNS
23rd Mar 2023 1:32 pm RNS HEMO-CAR-T Analytical Release Tests Completed

From todays RNS -
The completion of the full set of analytical tests of all PQ runs is the last manufacturing requirement that is necessary for the submission of an Investigational New Drug ("IND") application to the US Food and Drug Administration ("FDA"), which is now in the course of preparation. The IND is needed to obtain authorization from the FDA to commence Phase I clinical trials of HEMO-CAR-T. All PQ runs as well as analytical tests data will be compiled for inclusion in the IND submission pack.

CAR T progressing with IND submission pack ready to strap to Speckled Jim the carrier Pigeon en route to the Clinical Trials ,

Which by Vlads Submission , is the real meat of a Stock Shifter & I agree , & with a continuous good news via RNS & in current volatile markets 2023 could be a transformational year for Hemo investors .

& while this tasty Goulash is cooking in the IND pot , Hemo have other strands of quality science potentially growing scientific fruit , # CBR

CBR allows the development of:

(1) off-the-shelf cell therapies against infectious disease.

(2) biopharmaceuticals to eliminate any potential virus in the course of infection or to be used as a preventive treatment.

2023 could be a transformational year for Hemo & so far nothing but positive news & carrying out multiple strands of mind boggling superb science .

Good luck to all invested , & with last weeks clarification on IND position perhaps will quell the whinging on here or maybe not …

Fetch the IND Grog

Nice kipper after the bell at full ask

Date Time Trade Prc Volume Buy/Sell Bid Ask Value
24-Mar-23 16:32:52 2.09 800,000 Buy* 2.00 2.10 16.72k O

Fetch the IND Grog served by the Brazilian ladies mud wrestling champions wearing nothing but a seaweed thong & a lick of goose fat

Closing off a decent week after bagging a decent RNS
Pre IND tests complete

Rough Seas on the markets so a flat finish will suffice .
Closing price 2.05
Vol 5.6 million - light
Vwap 2.07

Quick - clarification of this weeks news >

Exactly 2 month after the last relevant to CAR T

Previous RNS -
23rd Jan 2023 7:00 am RNS HEMO-CAR-T 3rd Process Qualification Run Completed

From that RNS -
This PQ run is the third of minimum three identical manufacturing runs required for the submission of an Investigational New Drug ("IND") application to the US Food and Drug Administration ("FDA"). The IND is needed to obtain authorization from the FDA to commence Phase I clinical trials of HEMO-CAR-T. Following completion of all tests across all PQ runs, data will be compiled for inclusion in the IND submission pack.

Todays RNS
23rd Mar 2023 1:32 pm RNS HEMO-CAR-T Analytical Release Tests Completed

From todays RNS -
The completion of the full set of analytical tests of all PQ runs is the last manufacturing requirement that is necessary for the submission of an Investigational New Drug ("IND") application to the US Food and Drug Administration ("FDA"), which is now in the course of preparation. The IND is needed to obtain authorization from the FDA to commence Phase I clinical trials of HEMO-CAR-T. All PQ runs as well as analytical tests data will be compiled for inclusion in the IND submission pack.

CAR T progressing with IND submission pack ready to strap to Speckled Jim the carrier Pigeon en route to the Clinical Trials ,

Which by Vlads Submission , is the real meat of a Stock Shifter & I agree , & with a continuous good news via RNS & in current volatile markets 2023 could be a transformational year for Hemo investors .

& while this tasty Goulash is cooking in the IND pot , Hemo have other strands of quality science potentially growing scientific fruit , # CBR

CBR allows the development of:

(1) off-the-shelf cell therapies against infectious disease.

(2) biopharmaceuticals to eliminate any potential virus in the course of infection or to be used as a preventive treatment.

Good luck to all invested

Fetch the IND weekend Grog

Friday pm the stock in the Blue in very rough markets
Bagged another quality RNS yesterday

Yet some are bombarding this forum with multiple posts of negative hornswaggle ,
Sounds tedious, have a Rum & loosen your tight bullets .

Pre IND tests completed by both parties

Fetch the IND Grog